Skip to content
Recall Observatory FDA recall evidence

Drug product

Meprobamate; Tablets USP, 400 mg, 100 tablets; Rx only; Manufactured By: Watson Laboratories, Inc., Corona, CA 92800 USA; 173266; . Distributed by: Watson Pharma, Inc., NDC 0591-5238-01

D-204-2013

February 08, 2013

Class II

Product summary

Firm
Watson Laboratories Inc
Event
Event 64312
Status
Terminated
Classification
Class II
Quantity
20,587 bottles
Official record key
drug-enforcement:D-204-2013

Official wording

Reason: Failed Impurities/Degradation Specifications: Watson Laboratories Inc. is recalling meprobamate because an out of specification result for an impurity diphenyl sulfone .

Code information: 387879A, Exp. 02/13; 429105A, Exp. 06/13; 474488A, Exp. 11/13; 491672A, Exp. 01/14; 529095A, Exp. 04/14

Distribution pattern: Nationwide and Puerto Rico

Derived failure modes

  • Potency or specification failure

    reason.potency_specification_failure · v1.0.0

    out of specification